Clinical and Biochemical Characteristics of Brain-Dead Donors as Predictors of Early- and Long-Term Renal Function After Transplant

Exp Clin Transplant. 2017 Aug;15(4):387-393. doi: 10.6002/ect.2016.0145. Epub 2017 Jun 16.

Abstract

Objectives: Organs from brain-dead donors are the main source of allografts for transplant. Comparisons between living-donor and brain-dead donor kidneys show that the latter are more likely to demonstrate delayed graft function and lower long-term survival. This study aimed to assess the effects of various clinical and biochemical factors of donors on early- and long-term renal function after transplant.

Materials and methods: We analyzed data from kidney recipients treated between 2006 and 2008 who received organs from brain-dead donors. Data from 54 donors and 89 recipients were analyzed.

Results: No relation was observed between donor sodium concentration and the presence of delayed graft function. Donor height was positively correlated with creatinine clearance in recipients in the 1 to 3 months after renal transplant. Donor diastolic blood pressure was negatively correlated with estimated glomerular filtration rate throughout the observation period. Donor age was negatively correlated with the allograft recipient's estimated glomerular filtration rate throughout 4 years of observation. Donor estimated glomerular filtration rate was positively correlated with that of the recipient throughout 3 years of observation.

Conclusions: The results of this study indicate that various factors associated with allograft donors may influence graft function.

MeSH terms

  • Age Factors
  • Allografts
  • Biomarkers / blood
  • Blood Pressure
  • Body Height
  • Brain Death*
  • Creatinine / blood
  • Delayed Graft Function / blood
  • Delayed Graft Function / etiology
  • Delayed Graft Function / physiopathology
  • Donor Selection*
  • Glomerular Filtration Rate
  • Graft Survival
  • Humans
  • Kidney / physiopathology
  • Kidney / surgery*
  • Kidney Transplantation / adverse effects
  • Risk Factors
  • Sodium / blood
  • Time Factors
  • Tissue Donors / supply & distribution*
  • Treatment Outcome

Substances

  • Biomarkers
  • Sodium
  • Creatinine